Epiblastin A

CAS No. 16470-02-3

Epiblastin A( —— )

Catalog No. M23739 CAS No. 16470-02-3

Epiblastin A is an inhibitor of Casein Kinase 1 (CK1). Epiblastin A engages CK1 isoenzymes in cell lysate and induces efficient conversion of epiblast stem cells (EpiSCs) into embryonic stem cells (cESCs).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 36 In Stock
25MG 65 In Stock
50MG 91 In Stock
100MG 155 In Stock
200MG 230 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Epiblastin A
  • Note
    Research use only, not for human use.
  • Brief Description
    Epiblastin A is an inhibitor of Casein Kinase 1 (CK1). Epiblastin A engages CK1 isoenzymes in cell lysate and induces efficient conversion of epiblast stem cells (EpiSCs) into embryonic stem cells (cESCs).
  • Description
    Epiblastin A is an inhibitor of Casein Kinase 1 (CK1). Epiblastin A engages CK1 isoenzymes in cell lysate and induces efficient conversion of epiblast stem cells (EpiSCs) into embryonic stem cells (cESCs).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Casein Kinase
  • Recptor
    CK1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    16470-02-3
  • Formula Weight
    287.71
  • Molecular Formula
    C12H10ClN7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:2.5 mM
  • SMILES
    C1=CC(=CC(=C1)Cl)C2=NC3=C(N=C(N=C3N=C2N)N)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ursu A , Illich D J , Takemoto Y , et al. Epiblastin A Induces Reprogramming of Epiblast Stem Cells Into Embryonic Stem Cells by Inhibition of Casein Kinase 1[J]. Cell Chemical Biology, 2016, 23(4):494-507.
molnova catalog
related products
  • PF-670462

    PF-670462 is a potent (IC50 = 7.7 ± 2.2 nM) and selective inhibitor of CK1ε in isolated enzyme preparations.

  • CK1-IN-1

    CK1-IN-1 compound 1c reported in patent WO2015119579A1 is a casein kinase 1 (CK1) inhibitor. It has IC50s of 15 nM 16 nM 73 nM for CK1δ and CK1ε p38σ MAPK respectively.

  • CK2/ERK8-IN-1

    CK2/ERK8-IN-1 is a dual inhibitor of casein kinase 2 (CK2) (Ki: 0.25 μM) and ERK8 (IC50s: 0.50 μM) with pro-apoptotic efficacy.